India End-Stage Kidney Disease (ESKD) Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Dialysis, Kidney Transplantation, Medications & Supportive Care), By Modality (In-Center Dialysis, Home Dialysis), By End-User (Hospitals & Clinics, Dialysis Centers, Homecare Settings, Research & Academic Institutes, Others) and Forecasts, 2025-2033
USD 3800
India End-Stage Kidney Disease (ESKD) Treatment Market Insights
India’s ESKD treatment market is expanding rapidly, driven by a rising burden of diabetes, hypertension, and CKD. With over 200,000 new ESKD cases diagnosed annually, the country faces a growing need for affordable and accessible renal replacement therapies.
Key drivers include government programs like the Pradhan Mantri National Dialysis Programme, which aims to provide free dialysis services in public hospitals, and increasing investment in private dialysis centers across metro and semi-urban regions.
However, major restraints include inadequate nephrology infrastructure in rural areas, high out-of-pocket costs, and low awareness about CKD progression. India also faces a significant shortage of nephrologists and transplant donors.
Trends include the proliferation of low-cost dialysis chains, mobile dialysis units, and home-based peritoneal dialysis options. Startups and medtech firms are increasingly offering AI-powered health tracking and early CKD detection tools tailored for low-resource settings.
Opportunities lie in public-private partnerships, mass screening campaigns, and scalable training programs for nephrology personnel. With the right mix of affordability, innovation, and accessibility, India is well-positioned to transform its ESKD treatment landscape.
TABLE - India End-Stage Kidney Disease (ESKD) Treatment Market Size & Forecast By Treatment Type 2021-2033
| Treatment Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dialysis | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| - Hemodialysis | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| - Peritoneal Dialysis | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Kidney Transplantation | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| - Deceased Donor Transplant | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| - Living Donor Transplant | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Medications & Supportive Care | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| - Immunosuppressants | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| - Erythropoiesis-Stimulating Agents (ESA) | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| - Phosphate Binders | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis
TABLE - India End-Stage Kidney Disease (ESKD) Treatment Market Size & Forecast By Modality 2021-2033
| Modality | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In-Center Dialysis | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Home Dialysis | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis
TABLE - India End-Stage Kidney Disease (ESKD) Treatment Market Size & Forecast By End-User 2021-2033
| End-User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals & Clinics | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Dialysis Centers | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Homecare Settings | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Research & Academic Institutes | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Others | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
| Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis
Report Benefits
- Develop business strategies by understanding the trends shaping and driving the Market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track sales in the global and country-specific Market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.